Literature DB >> 31111172

SUPERNOVA: will its energy trigger the formation of a new therapeutic star?

Thomas Bein1, Audrey De Jong2, Anders Perner3.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31111172     DOI： 10.1007/s00134-019-05641-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  13 in total

Review 1.  Tidal volume reduction in patients with acute lung injury when plateau pressures are not high.

Authors:  David N Hager; Jerry A Krishnan; Douglas L Hayden; Roy G Brower
Journal:  Am J Respir Crit Care Med       Date:  2005-08-04       Impact factor: 21.405

2.  Extracorporeal membrane oxygenation: evolving epidemiology and mortality.

Authors:  Christian Karagiannidis; Daniel Brodie; Stephan Strassmann; Erich Stoelben; Alois Philipp; Thomas Bein; Thomas Müller; Wolfram Windisch
Journal:  Intensive Care Med       Date:  2016-03-04       Impact factor: 17.440

Review 3.  Extracorporeal carbon dioxide removal (ECCO2R) in patients with acute respiratory failure.

Authors:  Andrea Morelli; Lorenzo Del Sorbo; Antonio Pesenti; V Marco Ranieri; Eddy Fan
Journal:  Intensive Care Med       Date:  2017-01-28       Impact factor: 17.440

4.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.

Authors:  Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

5.  Feasibility and safety of extracorporeal CO2 removal to enhance protective ventilation in acute respiratory distress syndrome: the SUPERNOVA study.

Authors:  Alain Combes; Vito Fanelli; Tai Pham; V Marco Ranieri
Journal:  Intensive Care Med       Date:  2019-02-21       Impact factor: 17.440

6.  Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial.

Authors:  Giles J Peek; Miranda Mugford; Ravindranath Tiruvoipati; Andrew Wilson; Elizabeth Allen; Mariamma M Thalanany; Clare L Hibbert; Ann Truesdale; Felicity Clemens; Nicola Cooper; Richard K Firmin; Diana Elbourne
Journal:  Lancet       Date:  2009-09-15       Impact factor: 79.321

7.  From protective ventilation to super-protective ventilation for acute respiratory distress syndrome.

Authors:  Marcus J Schultz; Nicole P Juffermans; Michael A Matthay
Journal:  Intensive Care Med       Date:  2013-01-10       Impact factor: 17.440

Review 8.  Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics.

Authors:  Amber L Beitelshees; Deepak Voora; Joshua P Lewis
Journal:  Pharmgenomics Pers Med       Date:  2015-02-09

Review 9.  Physiological and Technical Considerations of Extracorporeal CO2 Removal.

Authors:  Christian Karagiannidis; Felix Hesselmann; Eddy Fan
Journal:  Crit Care       Date:  2019-03-09       Impact factor: 9.097

10.  Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus 'conventional' protective ventilation (6 ml/kg) in severe ARDS: the prospective randomized Xtravent-study.

Authors:  Thomas Bein; Steffen Weber-Carstens; Anton Goldmann; Thomas Müller; Thomas Staudinger; Jörg Brederlau; Ralf Muellenbach; Rolf Dembinski; Bernhard M Graf; Marlene Wewalka; Alois Philipp; Klaus-Dieter Wernecke; Matthias Lubnow; Arthur S Slutsky
Journal:  Intensive Care Med       Date:  2013-01-10       Impact factor: 17.440
View more
  1 in total

1.  A preliminary cost-effectiveness analysis of lung protective ventilation with extra corporeal carbon dioxide removal (ECCO2R) in the management of acute respiratory distress syndrome (ARDS).

Authors:  Oliver Ethgen; Jacques Goldstein; Kai Harenski; Armand Mekontso Dessap; Philippe Morimont; Michael Quintel; Alain Combes
Journal:  J Crit Care       Date:  2021-02-02       Impact factor: 3.425
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.